LION

Analyst Note: Lionsgate Studios Corp. (LION)

Date: 2026-06-13 Current Price: $15.49

1. Structural Readiness

• Conservative Entry: Not yet defined (requires a confirmed breakout above the coil resistance).
• Aggressive/Pre-Breakout Entry: Not applicable for a conservative strategy; currently observing the formation.
• Breakout Level: Not yet established (requires price to clear the coil resistance).
• Current Price: $15.49.
• Extension: Not applicable (price has not extended from a breakout).
• ATR Context: Current ATR is 4.7% (High). This falls within the historical "sweet spot" (4–6%) for structural quality, suggesting manageable volatility for position sizing if a breakout occurs, though it indicates elevated daily movement.

2. Thesis Layer

As of 2026-06-13, there is no named secular thesis attached to this setup. This is a TACTICAL, setup-led name. The conviction must be derived strictly from the quality of the technical structure (the forming coil) and the immediate business fundamentals disclosed in the most recent earnings and filings. No macro or thematic thesis should be invented to support the trade; the trade is on the setup and the company's operational execution.

3. Business Overview

Lionsgate Studios Corp. operates as a standalone, pure-play content company within the Communication Services sector, specifically the Motion Picture and Television Production industry.

• Core Operations: The company integrates motion picture and television production, distribution, and a talent management powerhouse (3 Arts Entertainment). It manages a library of over 20,000 titles.
• Revenue Segments: As of the fiscal year ended March 31, 2026, the business is split between Motion Picture (60.8%) and Television Production (39.2%).
• Backlog & Revenue Visibility: Management reported a contractual backlog of $1.3 billion in future revenues and cash flows as of May 2026. Management expects 90% of this backlog to be recognized within the next 24 months.
• Content Slate & Renewals:
• The company secured renewals for 12 of 13 scripted series.
• This renewal rate sets the stage for episodic deliveries to nearly double from fiscal '26 to fiscal '27.
• Approximately 90% of these episodes are scheduled to fall in Q2, Q3, and Q4 of the upcoming fiscal year.
• Production is set to begin on *The Housemaid Secret* (based on the second book in a trilogy) later in 2026 for a December 17, 2027 release.
• Library & IP Strategy:
• Trailing 12-month library revenue remained above $1 billion, growing 5% year-over-year.
• Management expects that over the next 2 to 3 years, over half of the film, television, and live entertainment slates will be comprised of branded, repeatable intellectual properties (IP) owned or controlled by the company.
• The company has successfully pivoted from selling only 4 series to the "big 6" streamers in fiscal '22 to 17 series in fiscal '26, with 10 of those 17 ranking in the top 10 of their respective platforms.
• Financial Structure:
• Production Loans: $1,256.6 million secured by IP collateral, plus $215.3 million unsecured.
• Tax Credit Facility: Maximum principal of $380.0 million available.
• Unamortized Costs: Acquired film and TV libraries have $215.7 million in unamortized costs as of Dec 31, 2025, amortized over a weighted-average remaining period of 12.7 years.
• Starz Licensing: Revenue from Starz licensing agreements contributed $24.1 million (3 months) and $140.2 million (9 months) to net loss from continuing operations in the period ended Dec 31, 2025. Agreements extend through at least 2028 (library) and 2036 (theatrical).

4. Archetype and Conviction

• Archetype: Growth Leader.
• Fit: The company demonstrates clear growth characteristics through the doubling of episodic deliveries, the expansion of its library revenue, and the strategic shift toward high-value IP. The backlog of $1.3 billion provides a visible growth runway.
• Valuation Context:
• Forward consensus EPS is $0.30229 for FY1 and $0.39147 for FY2.
• At a current price of $15.49, the stock trades at approximately 51x FY1 EPS and 39x FY2 EPS. This implies the market is pricing in significant execution of the backlog and growth narrative.
• Conviction Stack:
• Thesis Strength: Low (Tactical/Setup-led only).
• Evidence Quality: High. The earnings transcript (May 21, 2026) and SEC filings (Feb/May 2026) provide specific, quantifiable data on backlog, renewals, and revenue growth.
• Setup Readiness: Partial. The coil is forming, not confirmed. This is a "watch" state, not a "buy" state for a conservative strategy.
• Rerating Potential: Dependent on the confirmation of the backlog recognition and the successful execution of the doubled slate.

5. Invalidations, Strengths, and Gaps

• What Would Strengthen: A confirmed breakout above the coil resistance (price action) combined with positive commentary on the speed of backlog monetization or higher-than-expected box office performance (e.g., *Michael* crossing the $1 billion mark as projected).
• Gaps in Evidence:
• Breakout Level: The specific resistance level to be broken is not quantified.
• Cash Flow Details: While backlog is high, specific details on the timing of cash collection versus the amortization of the $215.7 million in unamortized costs are not fully detailed in the snippets provided.
• Debt Maturity: While production loans are listed, specific maturity schedules or covenants are not detailed in the provided text.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key evidence: $1.3 billion backlog with 90% expected within 24 months; episodic deliveries doubling for fiscal '27; library revenue >$1B growing 5% YoY. Key risks: High valuation multiples (51x FY1 EPS) pricing in perfect execution; reliance on backlog recognition timing; potential for production delays or cost overruns on the doubled slate. Expected path: Management expects backlog monetization to drive revenue growth over the next 24 months; technical setup requires a breakout above coil resistance to confirm bullish momentum. Expected horizon: 3 to 6 months for the setup to resolve (breakout or invalidation).